Skip to main content

Management and Updates of Medullary Thyroid Cancer CME Registration

Tuesday, February 15, 2022
7 – 8 am

While medullary thyroid cancer remains a surgically treated malignancy, the opportunity for cure is dependent on early diagnosis and treatment. After a brief review of current treatment guidelines, panelists will participate in a semi-structured case-based discussion of disease management focusing on areas of critical importance to management and those that remain controversial.

Join us for a robust discussion based CME with representation from a multidisciplinary team of specialists from endocrinology, pathology and laboratory, medical oncology and surgical oncology.

Moderator: Susan Mandel, MD

Panelists: Virginia LiVolsi, MD, Kate Nathanson, MD, Lova Sun, MD, Rachel Kelz, MD

After participating in this activity, the learner should be able to:

  • Describe the diagnostic evaluation for a patient diagnosed with medullary thyroid cancer
  • Explain principles of appropriate surgical management
  • Discuss evidence-based surveillance strategies
  • Review the indications for systemic therapy

Register here

Penn Medicine, Philadelphia, PA 800-789-7366 © , The Trustees of the University of Pennsylvania

Powered by BroadcastMedBROADCASTMED